Twitter Beğeni Hilesi

NEW CDC report underscores #AntimicrobialResistance remains an urgent #PublicHealth threat. Check out the new data and share with others who are working to continue the fight against AR. bit.ly/ARThreats2022

📰 Extra! Extra! Read all about the 2024 updates to the IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Below are highlights from the Notable Updates from 2023 section. For more info: buff.ly/3WdrVyr #AntimicrobialResistance #IDTwitter

Curious- if your GN AST card has cefoxitin on it - how are you reporting it w/different Enterobacterales? Do you add any comments if susc or resistant to guide antibiotic selection? #IDTwitter #microtwitter #ClinMicro

Enhance your #QualityImprovement skills in healthcare! Join our virtual workshop on Sep 25, 2024, and learn practical applications for Infection Prevention and Antibiotic Stewardship. #InfectionControl #AntibioticStewardship Register: bit.ly/45BMGZ7

Our annual CLSI SIDP 2024 Webinar: Breaking Bad Bacteria: Mastering the 2024 CLSI Antimicrobial Susceptibility Testing Updates is back on Wednesday, August 7, 2024 with SIDP and ACCP. Free for CLSI members, register here >> ow.ly/zX6P50SFely.

Thank you Forbes Judy Stone for bringing attention to the blood culture shortage. forbes.com/sites/judyston…

Check out the article summary table for July!

Factors Associated with Poor Clinical and Microbiologic Outcomes in C. auris Bloodstream Infection: A Multicenter Retrospective Cohort Study academic.oup.com/cid/article-ab…

Providers find it difficult not to treat once they have a positive U/A or UCx, independent of whether it was appropriate to test and when they know the evidence doesn’t show a benefit in treating asymptomatic bacteriuria. Goal needs to be reducing testing. academic.oup.com/ofid/advance-a…

Retrospective review of a very challenging clinical entity, candida prosthetic joint infections, now in Clinical Infectious Diseases. Debridement, antibiotics, and implant retention assoc with lower rates of cure c/w 1- or 2-stage exchange. doi.org/10.1093/cid/ci…

Hey everyone! Conference registration! Share and register! education.memorialhermann.org/profile/web/in…

Nothing to see over here, just me becoming besties with the amazing ID pharmacists Washington University ID Division. Like I always say, an ID pharmacist is an ID attending’s attending.

Heard at MSGERC #MSG2024 from Oliver Cornely: Use of azoles in the yeasts formerly known as #candida

What a wonderful team to work with! I had such fun and learned so much debating fungal diagnostics and treatment strategies with amazing international experts monica slavin and Oliver Cornely at the MSGERC Biennial Meeting. #MSGERC2024

Look at this picture! #IYKYK MSGERC #MSG2024 #TitansOfMycology

Melissa Johnson: We can do better! MSGERC #MSGERC2024

Who is that guy? Another excellent session from #MSGERC2024 with Melissa Johnson Melissa Johnson on antifungal TDM and David Boulware David Boulware, MD MPH on single dose AmB vs crypto meningitis. Fantastic discussion session afterwards, as for every session here.

Tonight we honor the 3 Jacks with @msg_erc Lifetime Achievement Awards: Drs John Bennett, John Edwards, and Jack Sobel. Living legends of mycology! Shown here with another lifetime achievement awardee, Dr Carol Kauffman & their former mentees. Congratulations Jacks! #msgerc2024

Thank you to MSGERC for hosting such an amazing meeting & inviting me to present on Antifungal TDM. So proud of the work we are doing in this area to optimize outcomes for our patients. The talks, science, and networking were stellar - looking forward to all that is to come!

Fantastic talks & moderation this week MSGERC. Great new information from Neil Clancy & David Boulware, MD MPH on ocular manifestations of candidiasis and applications of high single dose LAmB, expertly moderated by Dr. Hong Nguyen. Looking forward to seeing additional work on this!